New digital toolkit aims to boost prostate cancer literacy across europe
NCT ID NCT07437482
First seen Mar 04, 2026 · Last updated Jun 20, 2026 · Updated 24 times
Summary
This study is testing a co-created digital health literacy tool designed to help people better understand prostate cancer prevention and care. Researchers will enroll 3,100 adults aged 40 and older, including patients, caregivers, and healthcare professionals, across six European countries. The goal is to see if the tool improves shared decision-making and knowledge about prostate cancer compared to usual care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH LITERACY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Miguel Hernández
Alicante, Spain
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Co-created digital health literacy intervention
What this could lead to
If successful, this could provide a proven strategy to help people better understand prostate cancer information and make more informed decisions with their doctors.
What could go wrong
This is an early-stage, observational-style trial focused on education, not a treatment. The intervention may not significantly change behavior or outcomes, and results may vary across different populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.